Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
15.67%Return on Equity
VS
Market
Sector
Industry
History
$ 34.65Close
$ 5.9 - $ 35.6 52-Week Range
Ticker Information
Ticker
STOKCompany Name
STOKE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSTOKE THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
STOK - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 334.94M | $ 52.48M | 15.67% |
| 3/31/2025 | $ 350.07M | $ 50.27M | 14.36% |
| 12/31/2024 | $ 229.02M | $ -88.98M | -38.85% |
| 9/30/2024 | $ 232.11M | $ -105.46M | -45.43% |
| 6/30/2024 | $ 242.71M | $ -103.57M | -42.67% |
| 3/31/2024 | $ 140.34M | $ -108.53M | -77.33% |
| 12/31/2023 | $ 159.56M | $ -104.7M | -65.62% |
| 9/30/2023 | $ 173M | $ -103.4M | -59.77% |
| 6/30/2023 | $ 190.19M | $ -104.97M | -55.19% |
| 3/31/2023 | $ 213.82M | $ -98.96M | -46.28% |
Key Performance Insights, Last 5 Years
- STOKE THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -24.85%.
- Over the past 5 years, STOKE THERAPEUTICS INC's average ROE has been -37.44%.
- The median ROE for STOKE THERAPEUTICS INC during this period was -41.04%
- STOKE THERAPEUTICS INC reached its highest ROE over the past 5 years at 15.67%.
- The lowest ROE recorded by STOKE THERAPEUTICS INC in the same timeframe -77.33%
STOKE THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for STOKE THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -47.84M ] / Equity [ $ 192.53M ]
(=) ROE [ -24.85% ] STOK - Return on Equity, Last 5 years
-77.33%
Minimum
Mar 31, 2024
15.67%
Maximum
Jun 30, 2025
-37.44%
Average
-41.04%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |